Electrochemical methods for detection of biomarkers of Chronic Obstructive Pulmonary Disease in serum and saliva

被引:38
作者
Chen, Xuan [1 ,2 ,3 ]
Dong, Tao [1 ,3 ]
Wei, Xueyong [2 ]
Yang, Zhaochu [1 ]
Pires, Nuno Miguel Matos [1 ]
Ren, Juan [2 ]
Jiang, Zhuangde [2 ]
机构
[1] Chongqing Technol & Business Univ, Chongqing Key Lab Micronano Syst & Smart Transduc, Collaborat Innovat Ctr Micronano Transduct & Inte, Chongqing Key Lab Coll & Univ Micronano Syst Tech, Chongqing 400067, Peoples R China
[2] Xi An Jiao Tong Univ, State Key Lab Mfg Syst Engn, Xian 710049, Shaanxi, Peoples R China
[3] Univ South Eastern Norway, Fac Technol Nat Sci & Maritime Sci, Dept Microsyst IMS, Postboks 235, N-3603 Kongsberg, Norway
基金
中国国家自然科学基金;
关键词
Chronic obstructive pulmonary disease; Biomarkers; Electrochemical immunosensor; Enzyme-labelled immunosensor; Magnetoimmunosensor; FET immunosensor; C-REACTIVE PROTEIN; CARBON NANOTUBE FOREST; LABEL-FREE; ULTRASENSITIVE DETECTION; SYSTEMIC INFLAMMATION; CAPACITIVE BIOSENSOR; ELECTRONIC DETECTION; SENSITIVE DETECTION; LUNG-FUNCTION; COPD;
D O I
10.1016/j.bios.2019.111453
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death nowadays, and its under-diagnosis is still a great challenge. More effective diagnosis method is in urgent need since the traditional spirometry has many limitations in the practical application. The electrochemical (EC) detection methods have their unique advantages of high accuracy, short response time and easy integration of the system. In this review, recent works on the EC methods for COPD biomarkers including interleukin 6 (IL-6), interleukin 8 (IL-8) and Creactive protein (CRP) are summarized. Five types of EC methods are highlighted in this study, as enzyme-labelled immunosensors, nanoparticle-labelled immunosensors, capacitive or impedimetric immunosensors, magnetoimmunosensors, and field effect transistor (FET) immunosensors. To date, EC immunosensors have been exhibiting high analytical performance with a detection limit that can achieve several pg/mL or even lower. The simplicity of EC immunosensors makes them a perfect solution for a future point-of-care device to use in settings for COPD diagnosis and follow-up. Nevertheless, more efforts need to be paid on the simultaneous detection of multiple biomarkers, a demand for the clinical diagnosis, and processes of assay simplification towards achieving one-step detection.
引用
收藏
页数:18
相关论文
共 125 条
[1]   Multi analyte profiling and variability of inflammatory markers in blood and induced sputum in patients with stable COPD [J].
Aaron, Shawn D. ;
Vandemheen, Katherine L. ;
Ramsay, Timothy ;
Zhang, Chun ;
Avnur, Zafrira ;
Nikolcheva, Tania ;
Quinn, Anthony .
RESPIRATORY RESEARCH, 2010, 11
[2]   Biomarkers, the control panel and personalized COPD medicine [J].
Agusti, Alvar ;
Gea, Joaquim ;
Faner, Rosa .
RESPIROLOGY, 2016, 21 (01) :24-33
[3]   How often is diagnosis of COPD confirmed with spirometry? [J].
Arne, Mats ;
Lisspers, Karin ;
Stallberg, Bjorn ;
Boman, Gunnar ;
Hedenstrom, Hans ;
Janson, Christer ;
Emtner, Margareta .
RESPIRATORY MEDICINE, 2010, 104 (04) :550-556
[4]   Novel trends in affinity biosensors: current challenges and perspectives [J].
Arugula, Mary A. ;
Simonian, Aleksandr .
MEASUREMENT SCIENCE AND TECHNOLOGY, 2014, 25 (03)
[5]   An impedimetric immunosensor for highly sensitive detection of IL-8 in human serum and saliva samples: A new surface modification method by 6-phosphonohexanoic acid for biosensing applications [J].
Aydin, Elif Burcu ;
Sezginturk, Mustafa Kemal .
ANALYTICAL BIOCHEMISTRY, 2018, 554 :44-52
[6]   A highly selective electrochemical immunosensor based on conductive carbon black and star PGMA polymer composite material for IL-8 biomarker detection in human serum and saliva [J].
Aydin, Muhammet ;
Aydin, Elif Burcu ;
Sezginturk, Mustafa Kemal .
BIOSENSORS & BIOELECTRONICS, 2018, 117 :720-728
[7]  
Barnes Peter J, 2004, COPD, V1, P59, DOI 10.1081/COPD-120028701
[8]  
Bathoorn Erik, 2009, Int J Chron Obstruct Pulmon Dis, V4, P101
[9]   Prevalence, severity and underdiagnosis of COPD in the primary care setting [J].
Bednarek, M. ;
Maciejewski, J. ;
Wozniak, M. ;
Kuca, P. ;
Zielinski, J. .
THORAX, 2008, 63 (05) :402-407
[10]  
Bettazzi F, 2013, BIOANALYSIS, V5, P11, DOI [10.4155/bio.12.293, 10.4155/BIO.12.293]